We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK TO RENEW PARTICIPATION IN GOVERNMENT AIDS DRUG TRIAL
GSK TO RENEW PARTICIPATION IN GOVERNMENT AIDS DRUG TRIAL
July 1, 2004
Hours after being chastised by Rep. Henry Waxman (D-Calif.) for dropping out of a major clinical trial involving HIV treatment in African and other developing countries, GlaxoSmithKline (GSK) reversed course and said it would participate in the study.